Bowel cancer Cancer Malignant neoplasms of digestive organs
Conditions
Interventions
Randomisation
The UCL research team will supply each GP practice with a template of the ‘study database’, which will contain a pre-set randomisation list. Participants added to the dat
Sponsors
University College London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Individuals (aged 55 years and 1 month) registered with a participating GP practice served by the Bowel Cancer Screening Centre in Hull
Exclusion criteria
Exclusion criteria: Individuals will be excluded if: 1. They do not meet the clinical eligibility criteria for BSS (i.e. they have had their large bowel removed; they have a stoma bag to collect their stool; they are currently being treated for inflammatory bowel disease; they are awaiting heart surgery or have had heart surgery in the last three months) 2. They are registered on the clinical system as being a type 2 objector/opt out (i.e. have indicated that their confidential information cannot be shared by NHS Digital for any purposes beyond their own immediate care) 3. They are known to be receiving palliative care 4. They have been diagnosed with cancer (of any type) in the past 12 months Further exclusions will apply at the GP practice’s discretion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of individuals attending a bowel scope screening appointment within each study group. Data on the attendance status of each person will be obtained at the end of the study, 12 weeks after the distribution of the final self-referral reminder letter/patient navigation call. The data will be obtained by NHS Digital, who will extract the ‘Date of attended appointment’ of each person from the NHS Bowel Cancer Screening System using each patient’s NHS Number. The NHS numbers will be removed from the dataset prior to transfer and analysis by the UCL research team. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The proportion of individuals attending screening within each group before and after the delivery of non-participant interventions (i.e. uptake within each group before and after the delivery of the self-referral reminder letter/patient navigation telephone call). Data on the attendance status of each person will be obtained immediately before the delivery of non-participant interventions and again 12 weeks after the distribution of the final self-referral reminder/patient navigation telephone call. This information will be obtained by the GP Practice and NHS Digital, who will record the ‘Hub letter outcome’ (which reports attendance at the appointment offered by the NHS Bowel Cancer Screening Programme and is used to determine which individuals in the intervention groups should receive non-participant interventions) and ‘Date of attended appointment’ respectively. Comparisons between the interventions groups (Groups 2 and 3) and the control (Group 1), immediately before the delivery of the non-participant interventions, will then be used to determine the impact of the primer letter on uptake. Comparisons within groups, immediately before the delivery of non-participant interventions and 12 weeks after the delivery of the final self-referral reminder letter/patient navigation call, will conversely be used to assess the impact of the self-referral reminder letter and patient navigation call on uptake. Again, all data will be anonymised prior to analysis by the UCL research team. 2. The demographic composition of individuals who respond to self-referral reminder letters and patient navigation telephone calls. Data on the sex and ethnicity of each person will be added to the dataset using data within the GP Clinical System. Data on the area-level deprivation of each person’s home address will also be added to the dataset. This will also be done by the GP practice, who will convert the postcode of the individual’s home address (also available on the G | — |
Countries
United Kingdom
Outcome results
None listed